SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-24-002595
Filing Date
2024-03-12
Accepted
2024-03-12 16:20:36
Documents
1
Period of Report
2024-03-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 4108
  Complete submission text file 0001562180-24-002595.txt   5633
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Issuer) CIK: 0001822791 (see all company filings)

IRS No.: 852828339 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 500 PRINCIPIO PARKWAY WEST SUITE 400 NORTH EAST MD 21901
Business Address
Kiernan Matthew (Reporting) CIK: 0001993183 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39834 | Film No.: 24742357